Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2008

01-05-2008 | Melanomas

Tumor-Positive Sentinel Node Biopsy of the Groin in Clinically Node-Negative Melanoma Patients: Superficial or Superficial and Deep Lymph Node Dissection?

Authors: Iris M. C. van der Ploeg, Renato A. Valdés Olmos, Bin B. R. Kroon, Omgo E. Nieweg

Published in: Annals of Surgical Oncology | Issue 5/2008

Login to get access

Abstract

Background

The extent of a completion groin dissection in sentinel node–positive melanoma patients was guided by the location of the second-echelon nodes on the preoperative lymphoscintigram. The purposes of the current study were to investigate the pathological findings, the lymph node recurrences and (disease-free) survival associated with this approach.

Methods

Between June 1996 and April 2007, 42 patients underwent completion groin dissection after a tumor-positive sentinel node biopsy. Eighteen patients had femoro-inguinal second-echelon nodes on their lymphoscintigram and underwent a superficial lymph node dissection. Twenty-four patients had iliac-obturator second-echelon nodes found by scan and underwent a combined superficial and deep dissection.

Results

The median follow-up time was 61 months. One of the 18 patients who underwent a superficial groin dissection developed a deep (obturator) lymph node recurrence after 12 months. Revision of the lymphoscintigram showed that the images had been interpreted incorrectly and that the second-echelon node was located in the obturator area after all. A combined superficial and deep dissection revealed additional involved nodes in the deep lymph node compartment in 2 of the 24 patients. At 5 years, 77% of all patients were alive, and 56% were alive and free of disease. These figures were 76% and 53%, respectively, in the patients who underwent superficial dissection only, and 80% and 61%, respectively, in the patients who also underwent deep dissection.

Conclusions

This study suggests that a strategy to determine the extent of the groin dissection that is based on the location of the second-tier nodes may be valid.
Literature
1.
go back to reference Meyer T, Merkel S, Gohl J, et al. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol 2002;28:424–30.PubMedCrossRef Meyer T, Merkel S, Gohl J, et al. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol 2002;28:424–30.PubMedCrossRef
2.
go back to reference Hughes TM, A’Hern RP, Thomas JM Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000;87:892–901.PubMedCrossRef Hughes TM, A’Hern RP, Thomas JM Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000;87:892–901.PubMedCrossRef
3.
go back to reference Kretschmer L, Neumann C, Preusser KP, et al. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin-an analysis of survival and local recurrence. Acta Oncol 2001;40:72–8.PubMedCrossRef Kretschmer L, Neumann C, Preusser KP, et al. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin-an analysis of survival and local recurrence. Acta Oncol 2001;40:72–8.PubMedCrossRef
4.
go back to reference Mack LA, McKinnon JG Controversies in the management of metastatic melanoma to regional lymphatic basins. J Surg Oncol 2004;86:189–99.PubMedCrossRef Mack LA, McKinnon JG Controversies in the management of metastatic melanoma to regional lymphatic basins. J Surg Oncol 2004;86:189–99.PubMedCrossRef
5.
go back to reference Estourgie SH, Nieweg OE, Valdés Olmos RA, et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681–8.PubMedCrossRef Estourgie SH, Nieweg OE, Valdés Olmos RA, et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681–8.PubMedCrossRef
6.
go back to reference Jansen L, Nieweg OE, Peterse JL, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000;87:484–9.PubMedCrossRef Jansen L, Nieweg OE, Peterse JL, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000;87:484–9.PubMedCrossRef
7.
go back to reference Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.PubMed Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.PubMed
8.
9.
go back to reference Jonk A, Kroon BB, Rumke P, et al. Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both. Surg Gynecol Obstet 1988;167:28–32.PubMed Jonk A, Kroon BB, Rumke P, et al. Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both. Surg Gynecol Obstet 1988;167:28–32.PubMed
10.
go back to reference Singletary SE, Shallenberger R, Guinee VF Surgical management of groin nodal metastases from primary melanoma of the lower extremity. Surg Gynecol Obstet 1992;174:195–200.PubMed Singletary SE, Shallenberger R, Guinee VF Surgical management of groin nodal metastases from primary melanoma of the lower extremity. Surg Gynecol Obstet 1992;174:195–200.PubMed
11.
go back to reference Beitsch P, Balch C Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg 1992;164:462–5.PubMedCrossRef Beitsch P, Balch C Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg 1992;164:462–5.PubMedCrossRef
12.
go back to reference Balch CM, Ross MI Melanoma patients with iliac nodal metastases can be cured. Ann Surg Oncol 1999;6:230–1.PubMedCrossRef Balch CM, Ross MI Melanoma patients with iliac nodal metastases can be cured. Ann Surg Oncol 1999;6:230–1.PubMedCrossRef
13.
go back to reference Hughes TM, Thomas JM Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg 1999;86:1493–8.PubMedCrossRef Hughes TM, Thomas JM Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg 1999;86:1493–8.PubMedCrossRef
14.
go back to reference Karakousis CP, Driscoll DL Positive deep nodes in the groin and survival in malignant melanoma. Am J Surg 1996;171:421–2.PubMedCrossRef Karakousis CP, Driscoll DL Positive deep nodes in the groin and survival in malignant melanoma. Am J Surg 1996;171:421–2.PubMedCrossRef
15.
go back to reference Kissin MW, Simpson DA, Easton D, et al. Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma. Br J Surg 1987;74:1023–6.PubMedCrossRef Kissin MW, Simpson DA, Easton D, et al. Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma. Br J Surg 1987;74:1023–6.PubMedCrossRef
16.
go back to reference Mann GB, Coit DG Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol 1999;6:263–71.PubMedCrossRef Mann GB, Coit DG Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol 1999;6:263–71.PubMedCrossRef
17.
go back to reference Strobbe LJ, Jonk A, Hart AA, et al. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol 1999;6:255–62.PubMedCrossRef Strobbe LJ, Jonk A, Hart AA, et al. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol 1999;6:255–62.PubMedCrossRef
18.
go back to reference Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–83.PubMed Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–83.PubMed
19.
go back to reference McMasters KM, Wong SL, Edwards MJ, et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002;9:137–41.PubMedCrossRef McMasters KM, Wong SL, Edwards MJ, et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002;9:137–41.PubMedCrossRef
20.
go back to reference Reeves ME, Delgado R, Busam KJ, et al. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 2003;10:27–31.PubMedCrossRef Reeves ME, Delgado R, Busam KJ, et al. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 2003;10:27–31.PubMedCrossRef
21.
go back to reference Sabel MS, Gibbs JF, Cheney R, et al. Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute-designated cancer center. Surgery 2000;128:556–63.PubMedCrossRef Sabel MS, Gibbs JF, Cheney R, et al. Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute-designated cancer center. Surgery 2000;128:556–63.PubMedCrossRef
22.
go back to reference Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–17.PubMedCrossRef Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–17.PubMedCrossRef
23.
go back to reference Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302–11.PubMed Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302–11.PubMed
24.
go back to reference Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453–63.PubMedCrossRef Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453–63.PubMedCrossRef
25.
go back to reference Essner R, Scheri R, Kavanagh M, et al. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Arch Surg 2006;141:877–82.PubMedCrossRef Essner R, Scheri R, Kavanagh M, et al. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Arch Surg 2006;141:877–82.PubMedCrossRef
26.
go back to reference Page AJ, Carlson GW, Delman KA, et al. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Am Surg 2007;73:674–8.PubMed Page AJ, Carlson GW, Delman KA, et al. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Am Surg 2007;73:674–8.PubMed
27.
go back to reference Shen P, Conforti AM, Essner R, et al. Is the node of Cloquet the sentinel node for the iliac/obturator node group? Cancer J 2000;6:93–7.PubMed Shen P, Conforti AM, Essner R, et al. Is the node of Cloquet the sentinel node for the iliac/obturator node group? Cancer J 2000;6:93–7.PubMed
29.
go back to reference Coit DG, Brennan MF Extent of lymph node dissection in melanoma of the trunk or lower extremity. Arch Surg 1989;124:162–6.PubMed Coit DG, Brennan MF Extent of lymph node dissection in melanoma of the trunk or lower extremity. Arch Surg 1989;124:162–6.PubMed
30.
go back to reference Strobbe LJ, Jonk A, Hart AA, et al. The value of Cloquet’s node in predicting melanoma nodal metastases in the pelvic lymph node basin. Ann Surg Oncol 2001;8:209–14.PubMed Strobbe LJ, Jonk A, Hart AA, et al. The value of Cloquet’s node in predicting melanoma nodal metastases in the pelvic lymph node basin. Ann Surg Oncol 2001;8:209–14.PubMed
31.
go back to reference Hughes TM, A’Hern RP, Thomas JM Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000;87:892–901.PubMedCrossRef Hughes TM, A’Hern RP, Thomas JM Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000;87:892–901.PubMedCrossRef
32.
go back to reference McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004;86:212–23.PubMedCrossRef McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004;86:212–23.PubMedCrossRef
Metadata
Title
Tumor-Positive Sentinel Node Biopsy of the Groin in Clinically Node-Negative Melanoma Patients: Superficial or Superficial and Deep Lymph Node Dissection?
Authors
Iris M. C. van der Ploeg
Renato A. Valdés Olmos
Bin B. R. Kroon
Omgo E. Nieweg
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 5/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-9840-2

Other articles of this Issue 5/2008

Annals of Surgical Oncology 5/2008 Go to the issue